35th Congress of the European Society for Medical Oncology (ESMO) October 8-12, 2010, Milan, Italy (Conference Report) (Conference Notes‪)‬

Introduction This year's meeting revealed innovative progress from clinical trials, new drugs and therapy developments. Scientific advancement of genetic and proteomic profiling was highlighted, as well as the identification of microRNAs for diagnosis. The focus of this meeting was on the use of molecular-targeted therapies with acceptable safety profiles to treat different cancers. The quality of the scientific programme at this congress was extremely high, and a number of studies will be remembered because of their implications for oncology practice.